US Archives - Page 4 of 121 - European Medical Journal

Salivary Ultrasound Adds Value in Sjögren’s Diagnosis

Salivary gland ultrasound (SGUS) demonstrated meaningful diagnostic value for patients with highly suspected Sjögren’s Disease (SjD), particularly when combined with established serological or biopsy measures, according to findings from a prospective monocentric study.

Scalp Micropigmentation Shows Strong Results in Alopecia

Scalp micropigmentation (SMP) demonstrated effective and safe cosmetic improvement for patients with localized alopecia, according to a technical analysis and case series.

TAR-200 Shows Strong Responses in High-Risk Bladder Cancer

TAR-200, an investigational intravesical drug-releasing system delivering sustained gemcitabine, demonstrated high response rates and durable outcomes in patients with bacillus Calmette-Guérin (BCG)–unresponsive high-risk non–muscle-invasive bladder cancer (NMIBC), according to results from the Phase IIb SunRISe-1 study.

Females with PTSD Show Working Memory Deficits

Females with posttraumatic stress disorder showed reduced non-emotional working memory capacity and slower responses on the N-back task, with 2-back slowing linked to greater avoidance and overall symptom severity.

Latest Insights on GLP-1 Therapy for Sleep Apnea

GLP-1 receptor agonists (GLP-1RA) are emerging as a potential therapeutic option for patients with obstructive sleep apnea (OSA), according to a recent review that examined growing clinical evidence.

Psoriatic Disease in U.S. Patients Often Underdiagnosed

A new U.S. analysis of patient experiences with psoriatic disease highlights significant diagnostic delays, emotional burden, and potential underdiagnosis of psoriatic arthritis (PsA).

IDSA Guideline Update on Infliximab for Severe COVID-19

The latest clinical practice guideline update provides new recommendations on the use of infliximab for hospitalized adults with severe or critical COVID-19.

Hospitalizations Fall in Chronic Lymphocytic Leukemia Thanks to Continuity of Care

Patients with chronic lymphocytic leukemia (CLL) who consistently saw the same oncologist or hematologist experienced significantly fewer emergency room visits and hospitalizations, according to a large real-world study of nearly 6,000 individuals treated with covalent Bruton tyrosine kinase inhibitor (cBTKi) therapy.

Alzheimer’s Studies Evolve with Bigger, Slower Trials

Randomized clinical trials in Alzheimer’s disease have grown substantially in scale and complexity over the past three decades, with modern studies increasingly designed to capture slower and more subtle therapeutic effects.

Interferon Nasal Spray Shows Protective Effect Against COVID-19

Daily prophylaxis with interferon-alpha (IFN-α) nasal spray significantly reduced the risk of COVID-19 infection in adult patients with cancer, according to findings from a randomized, double-blinded, placebo-controlled trial.